Investigating harmful ingredients in electronic cigarettes
Official title: Electronic Cigarettes: Emerging Ingredients, Acids, Toxicants, and Indicators of Non-Tobacco Nicotine
Funded at University of California Riverside · NIH-10884691 · Data updated 2026-11-12
This study is looking at the ingredients in e-cigarettes to find out if any of them could be harmful to your health, so everyone can make safer choices about vaping.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project start | August 15, 2023 |
| Project end | July 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $669,321 |
| NIH project number | 1R56ES034792-01A1 |
| Project ID | NIH-10884691 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include current e-cigarette users, particularly teenagers and young adults who may be exposed to these harmful ingredients.
✕Less likely to help
Patients who do not use e-cigarettes or are not affected by the toxicants in e-liquids may not receive any benefit from this research.
What this research studies
This research focuses on the changing chemistry of e-liquids used in electronic cigarettes, particularly the emerging ingredients that may pose health risks. The study will analyze 600 commercial e-cigarette products to identify harmful flavor chemicals and nicotine forms. By understanding the toxicological implications of these ingredients, the research aims to inform better regulation and public health strategies. Patients and the general public will benefit from insights into the safety of e-cigarette products.
Why it matters
Potential benefit: If successful, this research could lead to improved safety regulations for e-cigarettes, reducing health risks for users.
How similar studies have gone: Previous research has shown that analyzing the chemical composition of e-liquids can reveal significant health risks, indicating that this approach has potential for impactful findings.
Where this research is happening
-
University of California Riverside
Riverside, United States Active
Researchers
- Principal investigator: Talbot, Prudence — University of California Riverside
- Study coordinator: Talbot, Prudence
Related research
Other NIH-funded projects on the same topics.
-
Cellular programming by plant signaling in cancer and other diseases
Scientists are studying how plant cell signals control gene activity in the nucleus and mitochondria to understand faulty regulation that can occur in cancers and other disorders.
-
Caveolin-1 helps brain vessels stay healthy after juvenile concussion
A study in kids and young adults looks at how a protein called Caveolin-1 affects brain blood vessels after a mild concussion and whether targeting it could protect long-term brain health.
-
How tiny cell antennae control signals linked to birth defects and cancer
Researchers are looking for new proteins in cells' tiny antennae that control signals involved in certain birth defects and cancers to point toward future treatments.
-
New ways to make natural compounds that could fight cancer, Alzheimer's, and inflammation
A scientist team will make and test natural-looking molecules to see if they can block proteins linked to cancer, Alzheimer's disease, and inflammatory conditions.
-
Promoting Coping Skills to Reduce Health Gaps in Teens and Young Adults
A study tests a shift-and-persist coping approach to help racial/ethnic minority teens and young adults handle stress and reduce risks for chronic disease.
-
Laser particle barcoding to track live cells and their omics in breast cancer
A new technique uses special laser-coded particles to follow individual breast cancer cells in real time while linking their live behavior to multi-omics data.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.